Streetbeat News

Regulatory

SNES

SenesTech, Inc. has announced a partnership with a global leader in irrigation solutions to expand its Evolve soft bait fertility control solution into open field agriculture, starting with a California dairy and almond grower. Evolve aims to control rodent populations by reducing fertility rather than relying on poisons, which are restricted in California. This expansion into agriculture represents a significant market opportunity for SenesTech, as rodents destroy nearly 20% of the world's stored food supply.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:19 pm

NUBI

Nubia Brand International Corp. has announced that the conditions for its business combination with Honeycomb Battery Company have not been met. The definitive proxy statement filed with the SEC on November 8, 2023, outlined the conditions which remain unsatisfied. The companies are working to meet these conditions, including Nasdaq's approval for listing the post-combination stock. If the business combination is not completed by March 15, 2024, Nubia may redeem its Class A common stock at the price based on its trust account balance.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:11 pm

BTCUSD

Mercari, a Japanese e-commerce platform, will accept Bitcoin payments starting June 2024 through its subsidiary Melcoin, with sellers receiving Japanese yen. Mercari has grown significantly since 2013 and is expanding its cryptocurrency services. Próspera, a Honduran economic zone, now recognizes Bitcoin as a unit of account, promoting financial freedom. These moves indicate a growing trend of Bitcoin integration into mainstream commerce and finance.

Portfolio Pulse from Murtuza Merchant

January 08, 2024 | 2:10 pm

ADN

Advent Technologies Holdings, Inc. (ADN) has received approximately $1.83 million in funding from the Danish Energy Technology Development and Demonstration Program for a project on advanced fuel cell power converters. The project, involving a consortium including Aalborg University and other partners, aims to develop a modular DC-DC power converter for Advent's next-generation High-Temperature Proton Exchange Membrane fuel cell applications. The technology, which is expected to extend fuel cell lifetimes and double power density, is part of the EU-approved Green HiPo project in Greece.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:08 pm

VEV

Vicinity Motor Corp. (NASDAQ:VEV) has entered into a distribution agreement with Shift EV Trucks to open Vicinity Trucks West Toronto, a dealership dedicated to Vicinity's commercial electric vehicles. Shift EV Trucks, an established dealership since 2013, will now offer Vicinity's VMC 1200 trucks in West Toronto, aiming to expand into the commercial EV market. The partnership is expected to capitalize on the growing demand for commercial EVs, driven by lower ownership costs, regulatory support, and government incentives.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:07 pm

INCY

Incyte (NASDAQ:INCY) presented at the 42nd Annual J.P. Morgan Healthcare Conference, highlighting growth opportunities and updates in its pipeline. The company announced positive Phase 2 results for ruxolitinib cream (Opzelura) in treating hidradenitis suppurativa (HS) and plans for a Phase 3 study. Incyte also showcased early data for INCB123667, a CDK2 inhibitor showing promise in late-stage cancers. Updates on expanding leadership in MPNs and GVHD, as well as the dermatology franchise, were provided. Further financial guidance and clinical program updates are expected in the 2023 Q4 earnings call.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:02 pm

EIS

IZRL

The Israel-Hamas conflict has reached a three-month mark with recent escalations including the killing of a Hezbollah commander by Israel. The G7, led by the U.S., is seeking a rapid end to the military phase, while U.S. Secretary of State Antony Blinken is on a Middle East tour to initiate peace efforts. Israeli Defense Minister Yoav Gallant indicated a strategic shift in military operations. The iShares Israel MSCI ETF (EIS) has seen a plateau in performance after recovery, while the ARK Israel Innovative Technology ETF (IZRL) is down 3.7% year to date, and the Israeli shekel has depreciated against the U.S. dollar.

Portfolio Pulse from Piero Cingari

January 08, 2024 | 1:59 pm

MIRM

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) announced preliminary unaudited 2023 net revenue and provided corporate updates. The company expects Q4 revenue of $69M-$71M, slightly above the $68.27M estimate, and FY23 revenue of $178M-$180M, below the $185.4M estimate. LIVMARLI net product sales are projected to be $141M-$143M for 2023, an 89% increase from 2022. Mirum acquired CHOLBAM and CHENODAL, expanded LIVMARLI's US label, and grew its international business. The company is fully financed with a strong balance sheet and announced Eric Bjerkholt as CFO. Mirum anticipates continued revenue growth in 2024, with key milestones including FDA PDUFA date for LIVMARLI, NDA submission for CHENODAL, and interim analyses for volixibat studies.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:58 pm

ONCT

Trading for ONCT was halted and then resumed at 8:55 AM ET, with an update on news and resumption times provided.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:55 pm

CRMD

CorMedix Inc. (NASDAQ:CRMD) has announced updates on the commercial launch of DefenCath, including a submitted HCPCS application for a J-Code to CMS, ongoing discussions for Medicare Part B reimbursement, and interest from health systems. The inpatient launch is expected by April 15, 2024, and outpatient availability is anticipated no sooner than July 1, 2024, pending CMS decisions. CorMedix may set an initial list price for DefenCath before CMS's final determination, with plans to adjust it based on the outcome. The company has sufficient funds for the launch and is expanding its staff in preparation.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:54 pm